Par Pacific Holdings Inc
Change company Symbol lookup
Select an option...
PARR Par Pacific Holdings Inc
AOD Aberdeen Total Dynamic Dividend Fund
VIRX Viracta Therapeutics Inc
YELP Yelp Inc
CCLV Karbon-X Corp
NCBDF Bandai Namco Holdings Inc
GTN Gray Television Inc
BKD Brookdale Senior Living Inc
PMT PennyMac Mortgage Investment Trust
EVTVD Envirotech Vehicles Inc
Go

Energy : Oil, Gas & Consumable Fuels | Small Cap Value
Company profile

Par Pacific Holdings, Inc. owns and operates energy and infrastructure businesses. The Company operates through three segments: Refining, Retail and Logistics. Refining segment owns and operates approximately three refineries with total operating crude oil throughput capacity of over 154 thousand barrels per day (Mbpd) in Hawaii, Wyoming, and Washington. Retail segment includes retail outlets in Hawaii, Washington, and Idaho that sells gasoline, diesel and retail merchandise. Logistics segment owns and operates terminals, pipelines, a single point mooring (SPM), and trucking operations to distribute refined products throughout the islands of Oahu, Maui, Hawaii, Molokai, and Kauai. Its refinery in Newcastle, Wyoming, produces gasoline, jet fuel, ultra-low sulfur diesel (ULSD), and other associated refined products that are primarily marketed in Wyoming and South Dakota. It operates convenience stores at its Hawaii retail fuel outlets under its nomnom brand that sell merchandise.

Price
Delayed
$15.97
Day's Change
-0.59 (-3.56%)
Bid
--
Ask
--
B/A Size
--
Day's High
16.96
Day's Low
15.86
Volume
(Light)

Today's volume of 204,127 shares is on pace to be much lighter than PARR's 10-day average volume of 1,061,490 shares.

204,127

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ABBV, ARQQ and AXSM

1:02 pm ET May 18, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / May 18, 2022 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

AbbVie Inc. (NYSE:ABBV)

Investors Affected : April 30, 2021 - August 31, 2021

A class action has commenced on behalf of certain shareholders in AbbVie Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) safety concerns about Pfizer Inc.'s drug Xeljanz extended to Abbvie's drug Rinvoq and to other Janus kinase enzyme inhibitor drugs; (2) as a result, it was likely that the U.S. Food and Drug Administration would require additional safety warnings for Rinvoq and would delay the approval of additional treatment indications for Rinvoq; and (3) therefore, defendants' statements about the Company's business, operations, and prospects lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/abbvie-inc-loss-submission-form/?id=27428&from=1

Arqit Quantum Inc. f/k/a Centricus Acquisition Corp. (NASDAQ:ARQQ)

This lawsuit is on behalf of: (i) all persons or entities who purchased or otherwise acquired Arqit securities between September 7, 2021 and April 18, 2022, inclusive; and/or (ii) all holders of Centricus securities as of the record date for the special meeting of shareholders held on August 31, 2021 to consider approval of the merger between Arqit and Centricus (the "Merger") and entitled to vote on the Merger.

A class action has commenced on behalf of certain shareholders in Arqit Quantum Inc f/k/a Centricus Acquisition Corp. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Arqit's proposed encryption technology would require widespread adoption of new protocols and standards for telecommunications; (2) British cybersecurity officials questioned the viability of Arqit's proposed encryption technology in a meeting in 2020; (3) the British government was not an Arqit customer but, rather, providing grants to Arqit; (4) Arqit had little more than an early-stage prototype of its encryption system at the time of the Merger; and (5) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/arqit-quantum-inc-f-k-a-centricus-acquisition-corp-loss-submission-form/?id=27428&from=1

Axsome Therapeutics, Inc. (NASDAQ:AXSM)

Investors Affected : December 30, 2019 - April 22, 2022

A class action has commenced on behalf of certain shareholders in Axsome Therapeutics, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Axsome's chemistry, manufacturing, and control ("CMC") practices were deficient with respect to AXS-07, the Company's medicine for the acute treatment of migraine, and its manufacturing process; (ii) as a result, Axsome was unlikely to submit the AXS-07 New Drug Application ("NDA") on its initially represented timeline; (iii) the foregoing CMC issues remained unresolved at the time that the U.S. Food and Drug Administration ("FDA") reviewed the AXS-07 NDA; (iv) accordingly, the FDA was unlikely to approve the AXS-07 NDA; (v) as a result of all the foregoing, Axsome had overstated AXS-07's regulatory and commercial prospects; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/axsome-therapeutics-inc-loss-submission-form/?id=27428&from=1

The Gross Law Firm, Wednesday, May 18, 2022, Press release picture

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm

15 West 38th Street, 12th floor

New York, NY, 10018

Email: dg@securitiesclasslaw.com

Phone: (212) 537-9430

Fax: (833) 862-7770

SOURCE: The Gross Law Firm





View source version on accesswire.com:

https://www.accesswire.com/701907/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-ABBV-ARQQ-and-AXSM



comtex tracking

COMTEX_407405986/2457/2022-05-18T13:02:37

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.